Synopsis
0
EU WC
0
VMF
DRUG PRODUCT COMPOSITIONS0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDA Orange Book
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
Regulatory Info :
Registration Country : Italy
Brand Name : Pilocarpine Lux
Dosage Form :
Dosage Strength : Coll 10 Ml 2%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Pilocarpine Lux
Dosage Form :
Dosage Strength : Coll 10 Ml 1%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Canada
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
DOSAGE - SOLUTION;OPHTHALMIC - 1%
USFDA APPLICATION NUMBER - 200890
DOSAGE - SOLUTION;OPHTHALMIC - 2%
USFDA APPLICATION NUMBER - 200890
DOSAGE - SOLUTION;OPHTHALMIC - 4%
USFDA APPLICATION NUMBER - 200890
DOSAGE - TABLET;ORAL - 5MG
USFDA APPLICATION NUMBER - 20237
DOSAGE - TABLET;ORAL - 7.5MG
USFDA APPLICATION NUMBER - 20237
Related Excipient Companies
SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kirsch Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ACG Worldwide
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Aeon Procare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Corel Pharma Chem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Esteem Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Keval Exports
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kima Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Lonza Capsugel
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nitika Pharmaceutical Specialities
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nomisma Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Novo Excipients
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qianhao Chemical (Hebei) Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Qualicaps
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Silverline Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]The Dow Chemical Company
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Coating Systems & Additives
Controlled & Modified Release
SPI Pharma has been solving formulation challenges using superior functional materials.
Dosage Form : Tablet
Grade : Oral
Application : Coating Systems & Additives, Controlled & Modified Release
Excipient Details : ACTILLETS are microcrystalline cellulose spheres developed using advanced drug delivery technology to enable effective loading & coating of particles.
Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.
Dosage Form : Cream / Lotion / Ointment, Gel, Injectable / Parenteral, Softgel Capsule, Softgels
Grade : Parenteral, Topical, Oral
Brand Name : Polyethylene Glycol 400
Application : Fillers, Diluents & Binders, Film Formers & Plasticizers, Parenteral, Surfactant & Foaming Agents, Thickeners and Stabilizers, Topical
Excipient Details : PEG 400 is used as a suspending agent, stabilizer, plasticizer and filler in OSDs, liquids & semi-solids and as a solvent for parenteral formulations.
Fillers, Diluents & Binders
Thickeners and Stabilizers
Direct Compression
Granulation
Topical
Film Formers & Plasticizers
Parenteral
Co-Processed Excipients
Lubricants & Glidants
Solubilizers
Disintegrants & Superdisintegrants
Chewable & Orodispersible Aids
Empty Capsules
API Stability Enhancers
Taste Masking
Vegetarian Capsules
Coloring Agents
Emulsifying Agents
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
100
PharmaCompass offers a list of Pilocarpine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Pilocarpine Hydrochloride manufacturer or Pilocarpine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Pilocarpine Hydrochloride manufacturer or Pilocarpine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Pilocarpine Hydrochloride API Price utilized in the formulation of products. Pilocarpine Hydrochloride API Price is not always fixed or binding as the Pilocarpine Hydrochloride Price is obtained through a variety of data sources. The Pilocarpine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Pilocarpine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Pilocarpine, including repackagers and relabelers. The FDA regulates Pilocarpine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Pilocarpine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Pilocarpine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Pilocarpine supplier is an individual or a company that provides Pilocarpine active pharmaceutical ingredient (API) or Pilocarpine finished formulations upon request. The Pilocarpine suppliers may include Pilocarpine API manufacturers, exporters, distributors and traders.
click here to find a list of Pilocarpine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Pilocarpine DMF (Drug Master File) is a document detailing the whole manufacturing process of Pilocarpine active pharmaceutical ingredient (API) in detail. Different forms of Pilocarpine DMFs exist exist since differing nations have different regulations, such as Pilocarpine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Pilocarpine DMF submitted to regulatory agencies in the US is known as a USDMF. Pilocarpine USDMF includes data on Pilocarpine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Pilocarpine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Pilocarpine suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Pilocarpine Drug Master File in Japan (Pilocarpine JDMF) empowers Pilocarpine API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Pilocarpine JDMF during the approval evaluation for pharmaceutical products. At the time of Pilocarpine JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Pilocarpine suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Pilocarpine Drug Master File in Korea (Pilocarpine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Pilocarpine. The MFDS reviews the Pilocarpine KDMF as part of the drug registration process and uses the information provided in the Pilocarpine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Pilocarpine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Pilocarpine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Pilocarpine suppliers with KDMF on PharmaCompass.
A Pilocarpine CEP of the European Pharmacopoeia monograph is often referred to as a Pilocarpine Certificate of Suitability (COS). The purpose of a Pilocarpine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Pilocarpine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Pilocarpine to their clients by showing that a Pilocarpine CEP has been issued for it. The manufacturer submits a Pilocarpine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Pilocarpine CEP holder for the record. Additionally, the data presented in the Pilocarpine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Pilocarpine DMF.
A Pilocarpine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Pilocarpine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Pilocarpine suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Pilocarpine as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Pilocarpine API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Pilocarpine as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Pilocarpine and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Pilocarpine NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Pilocarpine suppliers with NDC on PharmaCompass.
Pilocarpine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Pilocarpine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Pilocarpine GMP manufacturer or Pilocarpine GMP API supplier for your needs.
A Pilocarpine CoA (Certificate of Analysis) is a formal document that attests to Pilocarpine's compliance with Pilocarpine specifications and serves as a tool for batch-level quality control.
Pilocarpine CoA mostly includes findings from lab analyses of a specific batch. For each Pilocarpine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Pilocarpine may be tested according to a variety of international standards, such as European Pharmacopoeia (Pilocarpine EP), Pilocarpine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Pilocarpine USP).
